nodes	percent_of_prediction	percent_of_DWPC	metapath
Salbutamol—CYP3A4—Topotecan—peripheral nervous system neoplasm	0.0499	0.332	CbGbCtD
Salbutamol—CYP3A4—Tretinoin—peripheral nervous system neoplasm	0.0464	0.308	CbGbCtD
Salbutamol—CYP3A4—Vincristine—peripheral nervous system neoplasm	0.0213	0.142	CbGbCtD
Salbutamol—CYP3A4—Etoposide—peripheral nervous system neoplasm	0.0195	0.13	CbGbCtD
Salbutamol—CYP3A4—Doxorubicin—peripheral nervous system neoplasm	0.0133	0.0885	CbGbCtD
Salbutamol—Terbutaline—BCHE—peripheral nervous system neoplasm	0.0062	0.755	CrCbGaD
Salbutamol—Nadolol—ABCB1—peripheral nervous system neoplasm	0.00201	0.245	CrCbGaD
Salbutamol—Body temperature increased—Vincristine—peripheral nervous system neoplasm	0.000469	0.000557	CcSEcCtD
Salbutamol—Dyspnoea—Cisplatin—peripheral nervous system neoplasm	0.000467	0.000555	CcSEcCtD
Salbutamol—Skin disorder—Etoposide—peripheral nervous system neoplasm	0.000466	0.000554	CcSEcCtD
Salbutamol—Hyperhidrosis—Etoposide—peripheral nervous system neoplasm	0.000464	0.000552	CcSEcCtD
Salbutamol—Abdominal pain upper—Doxorubicin—peripheral nervous system neoplasm	0.000463	0.00055	CcSEcCtD
Salbutamol—Hypokalaemia—Doxorubicin—peripheral nervous system neoplasm	0.000461	0.000548	CcSEcCtD
Salbutamol—Angina pectoris—Epirubicin—peripheral nervous system neoplasm	0.000461	0.000548	CcSEcCtD
Salbutamol—Anorexia—Etoposide—peripheral nervous system neoplasm	0.000458	0.000544	CcSEcCtD
Salbutamol—Decreased appetite—Cisplatin—peripheral nervous system neoplasm	0.000456	0.000542	CcSEcCtD
Salbutamol—Bronchitis—Epirubicin—peripheral nervous system neoplasm	0.000455	0.000541	CcSEcCtD
Salbutamol—Diarrhoea—Dactinomycin—peripheral nervous system neoplasm	0.000454	0.00054	CcSEcCtD
Salbutamol—Hypersensitivity—Alitretinoin—peripheral nervous system neoplasm	0.000453	0.000539	CcSEcCtD
Salbutamol—Nasopharyngitis—Doxorubicin—peripheral nervous system neoplasm	0.000453	0.000539	CcSEcCtD
Salbutamol—Gastrointestinal disorder—Cisplatin—peripheral nervous system neoplasm	0.000453	0.000538	CcSEcCtD
Salbutamol—Hypotension—Etoposide—peripheral nervous system neoplasm	0.000449	0.000533	CcSEcCtD
Salbutamol—Pain—Cisplatin—peripheral nervous system neoplasm	0.000448	0.000533	CcSEcCtD
Salbutamol—Dysuria—Epirubicin—peripheral nervous system neoplasm	0.000443	0.000526	CcSEcCtD
Salbutamol—Asthenia—Alitretinoin—peripheral nervous system neoplasm	0.000441	0.000525	CcSEcCtD
Salbutamol—Abdominal distension—Doxorubicin—peripheral nervous system neoplasm	0.000441	0.000524	CcSEcCtD
Salbutamol—Upper respiratory tract infection—Epirubicin—peripheral nervous system neoplasm	0.00044	0.000523	CcSEcCtD
Salbutamol—Asthma—Doxorubicin—peripheral nervous system neoplasm	0.000438	0.000521	CcSEcCtD
Salbutamol—Influenza—Doxorubicin—peripheral nervous system neoplasm	0.000438	0.000521	CcSEcCtD
Salbutamol—Hypersensitivity—Vincristine—peripheral nervous system neoplasm	0.000437	0.000519	CcSEcCtD
Salbutamol—Pruritus—Alitretinoin—peripheral nervous system neoplasm	0.000435	0.000517	CcSEcCtD
Salbutamol—Feeling abnormal—Cisplatin—peripheral nervous system neoplasm	0.000432	0.000513	CcSEcCtD
Salbutamol—Paraesthesia—Etoposide—peripheral nervous system neoplasm	0.000431	0.000512	CcSEcCtD
Salbutamol—Dyspnoea—Etoposide—peripheral nervous system neoplasm	0.000428	0.000509	CcSEcCtD
Salbutamol—Hyperglycaemia—Epirubicin—peripheral nervous system neoplasm	0.000427	0.000507	CcSEcCtD
Salbutamol—Somnolence—Etoposide—peripheral nervous system neoplasm	0.000427	0.000507	CcSEcCtD
Salbutamol—Angina pectoris—Doxorubicin—peripheral nervous system neoplasm	0.000427	0.000507	CcSEcCtD
Salbutamol—Asthenia—Vincristine—peripheral nervous system neoplasm	0.000425	0.000505	CcSEcCtD
Salbutamol—Drowsiness—Epirubicin—peripheral nervous system neoplasm	0.000422	0.000502	CcSEcCtD
Salbutamol—Vomiting—Dactinomycin—peripheral nervous system neoplasm	0.000422	0.000501	CcSEcCtD
Salbutamol—Bronchitis—Doxorubicin—peripheral nervous system neoplasm	0.000421	0.000501	CcSEcCtD
Salbutamol—Diarrhoea—Alitretinoin—peripheral nervous system neoplasm	0.000421	0.0005	CcSEcCtD
Salbutamol—Rash—Dactinomycin—peripheral nervous system neoplasm	0.000418	0.000497	CcSEcCtD
Salbutamol—Decreased appetite—Etoposide—peripheral nervous system neoplasm	0.000417	0.000496	CcSEcCtD
Salbutamol—Gastrointestinal disorder—Etoposide—peripheral nervous system neoplasm	0.000415	0.000493	CcSEcCtD
Salbutamol—Body temperature increased—Cisplatin—peripheral nervous system neoplasm	0.000414	0.000492	CcSEcCtD
Salbutamol—Fatigue—Etoposide—peripheral nervous system neoplasm	0.000414	0.000492	CcSEcCtD
Salbutamol—Neuropathy peripheral—Epirubicin—peripheral nervous system neoplasm	0.000414	0.000492	CcSEcCtD
Salbutamol—Stomatitis—Epirubicin—peripheral nervous system neoplasm	0.000411	0.000489	CcSEcCtD
Salbutamol—Jaundice—Epirubicin—peripheral nervous system neoplasm	0.000411	0.000489	CcSEcCtD
Salbutamol—Constipation—Etoposide—peripheral nervous system neoplasm	0.000411	0.000488	CcSEcCtD
Salbutamol—Pain—Etoposide—peripheral nervous system neoplasm	0.000411	0.000488	CcSEcCtD
Salbutamol—Urinary tract infection—Epirubicin—peripheral nervous system neoplasm	0.00041	0.000488	CcSEcCtD
Salbutamol—Conjunctivitis—Epirubicin—peripheral nervous system neoplasm	0.00041	0.000488	CcSEcCtD
Salbutamol—Dysuria—Doxorubicin—peripheral nervous system neoplasm	0.00041	0.000487	CcSEcCtD
Salbutamol—Upper respiratory tract infection—Doxorubicin—peripheral nervous system neoplasm	0.000407	0.000484	CcSEcCtD
Salbutamol—Dizziness—Alitretinoin—peripheral nervous system neoplasm	0.000407	0.000483	CcSEcCtD
Salbutamol—Diarrhoea—Vincristine—peripheral nervous system neoplasm	0.000406	0.000482	CcSEcCtD
Salbutamol—Sweating—Epirubicin—peripheral nervous system neoplasm	0.000405	0.000481	CcSEcCtD
Salbutamol—Haematuria—Epirubicin—peripheral nervous system neoplasm	0.000402	0.000478	CcSEcCtD
Salbutamol—Epistaxis—Epirubicin—peripheral nervous system neoplasm	0.000398	0.000473	CcSEcCtD
Salbutamol—Sinusitis—Epirubicin—peripheral nervous system neoplasm	0.000396	0.000471	CcSEcCtD
Salbutamol—Feeling abnormal—Etoposide—peripheral nervous system neoplasm	0.000396	0.00047	CcSEcCtD
Salbutamol—Hyperglycaemia—Doxorubicin—peripheral nervous system neoplasm	0.000395	0.00047	CcSEcCtD
Salbutamol—Nausea—Dactinomycin—peripheral nervous system neoplasm	0.000394	0.000468	CcSEcCtD
Salbutamol—Gastrointestinal pain—Etoposide—peripheral nervous system neoplasm	0.000393	0.000467	CcSEcCtD
Salbutamol—Dizziness—Vincristine—peripheral nervous system neoplasm	0.000392	0.000466	CcSEcCtD
Salbutamol—Vomiting—Alitretinoin—peripheral nervous system neoplasm	0.000391	0.000465	CcSEcCtD
Salbutamol—Drowsiness—Doxorubicin—peripheral nervous system neoplasm	0.00039	0.000464	CcSEcCtD
Salbutamol—Rash—Alitretinoin—peripheral nervous system neoplasm	0.000388	0.000461	CcSEcCtD
Salbutamol—Dermatitis—Alitretinoin—peripheral nervous system neoplasm	0.000388	0.000461	CcSEcCtD
Salbutamol—Hypersensitivity—Cisplatin—peripheral nervous system neoplasm	0.000386	0.000459	CcSEcCtD
Salbutamol—Headache—Alitretinoin—peripheral nervous system neoplasm	0.000385	0.000458	CcSEcCtD
Salbutamol—Neuropathy peripheral—Doxorubicin—peripheral nervous system neoplasm	0.000383	0.000455	CcSEcCtD
Salbutamol—Urticaria—Etoposide—peripheral nervous system neoplasm	0.000381	0.000453	CcSEcCtD
Salbutamol—Haemoglobin—Epirubicin—peripheral nervous system neoplasm	0.000381	0.000453	CcSEcCtD
Salbutamol—Jaundice—Doxorubicin—peripheral nervous system neoplasm	0.000381	0.000452	CcSEcCtD
Salbutamol—Stomatitis—Doxorubicin—peripheral nervous system neoplasm	0.000381	0.000452	CcSEcCtD
Salbutamol—Rhinitis—Epirubicin—peripheral nervous system neoplasm	0.00038	0.000451	CcSEcCtD
Salbutamol—Abdominal pain—Etoposide—peripheral nervous system neoplasm	0.00038	0.000451	CcSEcCtD
Salbutamol—Body temperature increased—Etoposide—peripheral nervous system neoplasm	0.00038	0.000451	CcSEcCtD
Salbutamol—Urinary tract infection—Doxorubicin—peripheral nervous system neoplasm	0.00038	0.000451	CcSEcCtD
Salbutamol—Conjunctivitis—Doxorubicin—peripheral nervous system neoplasm	0.00038	0.000451	CcSEcCtD
Salbutamol—Haemorrhage—Epirubicin—peripheral nervous system neoplasm	0.000379	0.00045	CcSEcCtD
Salbutamol—Hypoaesthesia—Epirubicin—peripheral nervous system neoplasm	0.000377	0.000448	CcSEcCtD
Salbutamol—Vomiting—Vincristine—peripheral nervous system neoplasm	0.000377	0.000448	CcSEcCtD
Salbutamol—Asthenia—Cisplatin—peripheral nervous system neoplasm	0.000376	0.000447	CcSEcCtD
Salbutamol—Pharyngitis—Epirubicin—peripheral nervous system neoplasm	0.000376	0.000447	CcSEcCtD
Salbutamol—Sweating—Doxorubicin—peripheral nervous system neoplasm	0.000374	0.000445	CcSEcCtD
Salbutamol—Urinary tract disorder—Epirubicin—peripheral nervous system neoplasm	0.000374	0.000445	CcSEcCtD
Salbutamol—Rash—Vincristine—peripheral nervous system neoplasm	0.000374	0.000444	CcSEcCtD
Salbutamol—Dermatitis—Vincristine—peripheral nervous system neoplasm	0.000373	0.000444	CcSEcCtD
Salbutamol—Haematuria—Doxorubicin—peripheral nervous system neoplasm	0.000372	0.000443	CcSEcCtD
Salbutamol—Connective tissue disorder—Epirubicin—peripheral nervous system neoplasm	0.000372	0.000442	CcSEcCtD
Salbutamol—Urethral disorder—Epirubicin—peripheral nervous system neoplasm	0.000371	0.000441	CcSEcCtD
Salbutamol—Headache—Vincristine—peripheral nervous system neoplasm	0.000371	0.000441	CcSEcCtD
Salbutamol—Epistaxis—Doxorubicin—peripheral nervous system neoplasm	0.000368	0.000438	CcSEcCtD
Salbutamol—Sinusitis—Doxorubicin—peripheral nervous system neoplasm	0.000366	0.000435	CcSEcCtD
Salbutamol—Nausea—Alitretinoin—peripheral nervous system neoplasm	0.000365	0.000434	CcSEcCtD
Salbutamol—Diarrhoea—Cisplatin—peripheral nervous system neoplasm	0.000359	0.000426	CcSEcCtD
Salbutamol—Hypersensitivity—Etoposide—peripheral nervous system neoplasm	0.000354	0.00042	CcSEcCtD
Salbutamol—Tinnitus—Epirubicin—peripheral nervous system neoplasm	0.000353	0.00042	CcSEcCtD
Salbutamol—Haemoglobin—Doxorubicin—peripheral nervous system neoplasm	0.000352	0.000419	CcSEcCtD
Salbutamol—Nausea—Vincristine—peripheral nervous system neoplasm	0.000352	0.000418	CcSEcCtD
Salbutamol—Cardiac disorder—Epirubicin—peripheral nervous system neoplasm	0.000352	0.000418	CcSEcCtD
Salbutamol—Flushing—Epirubicin—peripheral nervous system neoplasm	0.000352	0.000418	CcSEcCtD
Salbutamol—Rhinitis—Doxorubicin—peripheral nervous system neoplasm	0.000351	0.000418	CcSEcCtD
Salbutamol—Haemorrhage—Doxorubicin—peripheral nervous system neoplasm	0.000351	0.000417	CcSEcCtD
Salbutamol—Hypoaesthesia—Doxorubicin—peripheral nervous system neoplasm	0.000349	0.000415	CcSEcCtD
Salbutamol—Pharyngitis—Doxorubicin—peripheral nervous system neoplasm	0.000348	0.000414	CcSEcCtD
Salbutamol—Urinary tract disorder—Doxorubicin—peripheral nervous system neoplasm	0.000346	0.000411	CcSEcCtD
Salbutamol—Asthenia—Etoposide—peripheral nervous system neoplasm	0.000345	0.000409	CcSEcCtD
Salbutamol—Connective tissue disorder—Doxorubicin—peripheral nervous system neoplasm	0.000344	0.000409	CcSEcCtD
Salbutamol—Angiopathy—Epirubicin—peripheral nervous system neoplasm	0.000344	0.000409	CcSEcCtD
Salbutamol—Urethral disorder—Doxorubicin—peripheral nervous system neoplasm	0.000344	0.000408	CcSEcCtD
Salbutamol—Immune system disorder—Epirubicin—peripheral nervous system neoplasm	0.000342	0.000407	CcSEcCtD
Salbutamol—Mediastinal disorder—Epirubicin—peripheral nervous system neoplasm	0.000341	0.000406	CcSEcCtD
Salbutamol—Chills—Epirubicin—peripheral nervous system neoplasm	0.00034	0.000404	CcSEcCtD
Salbutamol—Pruritus—Etoposide—peripheral nervous system neoplasm	0.00034	0.000404	CcSEcCtD
Salbutamol—Arrhythmia—Epirubicin—peripheral nervous system neoplasm	0.000338	0.000402	CcSEcCtD
Salbutamol—Vomiting—Cisplatin—peripheral nervous system neoplasm	0.000333	0.000396	CcSEcCtD
Salbutamol—Mental disorder—Epirubicin—peripheral nervous system neoplasm	0.000332	0.000394	CcSEcCtD
Salbutamol—Rash—Cisplatin—peripheral nervous system neoplasm	0.00033	0.000393	CcSEcCtD
Salbutamol—Dermatitis—Cisplatin—peripheral nervous system neoplasm	0.00033	0.000392	CcSEcCtD
Salbutamol—Malnutrition—Epirubicin—peripheral nervous system neoplasm	0.00033	0.000392	CcSEcCtD
Salbutamol—Diarrhoea—Etoposide—peripheral nervous system neoplasm	0.000329	0.00039	CcSEcCtD
Salbutamol—Tinnitus—Doxorubicin—peripheral nervous system neoplasm	0.000327	0.000388	CcSEcCtD
Salbutamol—Cardiac disorder—Doxorubicin—peripheral nervous system neoplasm	0.000325	0.000387	CcSEcCtD
Salbutamol—Flushing—Doxorubicin—peripheral nervous system neoplasm	0.000325	0.000387	CcSEcCtD
Salbutamol—Flatulence—Epirubicin—peripheral nervous system neoplasm	0.000325	0.000386	CcSEcCtD
Salbutamol—Tension—Epirubicin—peripheral nervous system neoplasm	0.000324	0.000385	CcSEcCtD
Salbutamol—Dysgeusia—Epirubicin—peripheral nervous system neoplasm	0.000323	0.000384	CcSEcCtD
Salbutamol—Nervousness—Epirubicin—peripheral nervous system neoplasm	0.00032	0.000381	CcSEcCtD
Salbutamol—Back pain—Epirubicin—peripheral nervous system neoplasm	0.000319	0.000379	CcSEcCtD
Salbutamol—Angiopathy—Doxorubicin—peripheral nervous system neoplasm	0.000318	0.000378	CcSEcCtD
Salbutamol—Dizziness—Etoposide—peripheral nervous system neoplasm	0.000318	0.000377	CcSEcCtD
Salbutamol—Muscle spasms—Epirubicin—peripheral nervous system neoplasm	0.000317	0.000377	CcSEcCtD
Salbutamol—Immune system disorder—Doxorubicin—peripheral nervous system neoplasm	0.000317	0.000376	CcSEcCtD
Salbutamol—Mediastinal disorder—Doxorubicin—peripheral nervous system neoplasm	0.000316	0.000375	CcSEcCtD
Salbutamol—Chills—Doxorubicin—peripheral nervous system neoplasm	0.000315	0.000374	CcSEcCtD
Salbutamol—Arrhythmia—Doxorubicin—peripheral nervous system neoplasm	0.000313	0.000372	CcSEcCtD
Salbutamol—Nausea—Cisplatin—peripheral nervous system neoplasm	0.000311	0.00037	CcSEcCtD
Salbutamol—Mental disorder—Doxorubicin—peripheral nervous system neoplasm	0.000307	0.000365	CcSEcCtD
Salbutamol—Ill-defined disorder—Epirubicin—peripheral nervous system neoplasm	0.000306	0.000364	CcSEcCtD
Salbutamol—Vomiting—Etoposide—peripheral nervous system neoplasm	0.000305	0.000363	CcSEcCtD
Salbutamol—Malnutrition—Doxorubicin—peripheral nervous system neoplasm	0.000305	0.000363	CcSEcCtD
Salbutamol—Agitation—Epirubicin—peripheral nervous system neoplasm	0.000303	0.00036	CcSEcCtD
Salbutamol—Rash—Etoposide—peripheral nervous system neoplasm	0.000303	0.00036	CcSEcCtD
Salbutamol—Dermatitis—Etoposide—peripheral nervous system neoplasm	0.000302	0.00036	CcSEcCtD
Salbutamol—Headache—Etoposide—peripheral nervous system neoplasm	0.000301	0.000358	CcSEcCtD
Salbutamol—Flatulence—Doxorubicin—peripheral nervous system neoplasm	0.000301	0.000357	CcSEcCtD
Salbutamol—Tension—Doxorubicin—peripheral nervous system neoplasm	0.000299	0.000356	CcSEcCtD
Salbutamol—Dysgeusia—Doxorubicin—peripheral nervous system neoplasm	0.000299	0.000355	CcSEcCtD
Salbutamol—Malaise—Epirubicin—peripheral nervous system neoplasm	0.000297	0.000353	CcSEcCtD
Salbutamol—Nervousness—Doxorubicin—peripheral nervous system neoplasm	0.000296	0.000352	CcSEcCtD
Salbutamol—Vertigo—Epirubicin—peripheral nervous system neoplasm	0.000296	0.000352	CcSEcCtD
Salbutamol—Syncope—Epirubicin—peripheral nervous system neoplasm	0.000296	0.000352	CcSEcCtD
Salbutamol—Back pain—Doxorubicin—peripheral nervous system neoplasm	0.000295	0.000351	CcSEcCtD
Salbutamol—Muscle spasms—Doxorubicin—peripheral nervous system neoplasm	0.000293	0.000349	CcSEcCtD
Salbutamol—Palpitations—Epirubicin—peripheral nervous system neoplasm	0.000291	0.000346	CcSEcCtD
Salbutamol—Loss of consciousness—Epirubicin—peripheral nervous system neoplasm	0.00029	0.000345	CcSEcCtD
Salbutamol—Cough—Epirubicin—peripheral nervous system neoplasm	0.000288	0.000342	CcSEcCtD
Salbutamol—Nausea—Etoposide—peripheral nervous system neoplasm	0.000285	0.000339	CcSEcCtD
Salbutamol—Hypertension—Epirubicin—peripheral nervous system neoplasm	0.000285	0.000338	CcSEcCtD
Salbutamol—Ill-defined disorder—Doxorubicin—peripheral nervous system neoplasm	0.000283	0.000337	CcSEcCtD
Salbutamol—Chest pain—Epirubicin—peripheral nervous system neoplasm	0.000281	0.000334	CcSEcCtD
Salbutamol—Arthralgia—Epirubicin—peripheral nervous system neoplasm	0.000281	0.000334	CcSEcCtD
Salbutamol—Myalgia—Epirubicin—peripheral nervous system neoplasm	0.000281	0.000334	CcSEcCtD
Salbutamol—Agitation—Doxorubicin—peripheral nervous system neoplasm	0.00028	0.000333	CcSEcCtD
Salbutamol—Anxiety—Epirubicin—peripheral nervous system neoplasm	0.00028	0.000333	CcSEcCtD
Salbutamol—Discomfort—Epirubicin—peripheral nervous system neoplasm	0.000277	0.00033	CcSEcCtD
Salbutamol—Malaise—Doxorubicin—peripheral nervous system neoplasm	0.000275	0.000327	CcSEcCtD
Salbutamol—Dry mouth—Epirubicin—peripheral nervous system neoplasm	0.000275	0.000326	CcSEcCtD
Salbutamol—Vertigo—Doxorubicin—peripheral nervous system neoplasm	0.000274	0.000326	CcSEcCtD
Salbutamol—Syncope—Doxorubicin—peripheral nervous system neoplasm	0.000274	0.000325	CcSEcCtD
Salbutamol—Palpitations—Doxorubicin—peripheral nervous system neoplasm	0.00027	0.000321	CcSEcCtD
Salbutamol—Oedema—Epirubicin—peripheral nervous system neoplasm	0.000269	0.00032	CcSEcCtD
Salbutamol—Anaphylactic shock—Epirubicin—peripheral nervous system neoplasm	0.000269	0.00032	CcSEcCtD
Salbutamol—Loss of consciousness—Doxorubicin—peripheral nervous system neoplasm	0.000268	0.000319	CcSEcCtD
Salbutamol—Infection—Epirubicin—peripheral nervous system neoplasm	0.000267	0.000318	CcSEcCtD
Salbutamol—Cough—Doxorubicin—peripheral nervous system neoplasm	0.000266	0.000316	CcSEcCtD
Salbutamol—Shock—Epirubicin—peripheral nervous system neoplasm	0.000265	0.000315	CcSEcCtD
Salbutamol—Nervous system disorder—Epirubicin—peripheral nervous system neoplasm	0.000264	0.000314	CcSEcCtD
Salbutamol—Hypertension—Doxorubicin—peripheral nervous system neoplasm	0.000263	0.000313	CcSEcCtD
Salbutamol—Tachycardia—Epirubicin—peripheral nervous system neoplasm	0.000263	0.000312	CcSEcCtD
Salbutamol—Skin disorder—Epirubicin—peripheral nervous system neoplasm	0.000261	0.000311	CcSEcCtD
Salbutamol—Hyperhidrosis—Epirubicin—peripheral nervous system neoplasm	0.00026	0.000309	CcSEcCtD
Salbutamol—Arthralgia—Doxorubicin—peripheral nervous system neoplasm	0.00026	0.000309	CcSEcCtD
Salbutamol—Myalgia—Doxorubicin—peripheral nervous system neoplasm	0.00026	0.000309	CcSEcCtD
Salbutamol—Chest pain—Doxorubicin—peripheral nervous system neoplasm	0.00026	0.000309	CcSEcCtD
Salbutamol—Anxiety—Doxorubicin—peripheral nervous system neoplasm	0.000259	0.000308	CcSEcCtD
Salbutamol—Discomfort—Doxorubicin—peripheral nervous system neoplasm	0.000257	0.000305	CcSEcCtD
Salbutamol—Anorexia—Epirubicin—peripheral nervous system neoplasm	0.000257	0.000305	CcSEcCtD
Salbutamol—Dry mouth—Doxorubicin—peripheral nervous system neoplasm	0.000254	0.000302	CcSEcCtD
Salbutamol—Hypotension—Epirubicin—peripheral nervous system neoplasm	0.000252	0.000299	CcSEcCtD
Salbutamol—Oedema—Doxorubicin—peripheral nervous system neoplasm	0.000249	0.000296	CcSEcCtD
Salbutamol—Anaphylactic shock—Doxorubicin—peripheral nervous system neoplasm	0.000249	0.000296	CcSEcCtD
Salbutamol—Infection—Doxorubicin—peripheral nervous system neoplasm	0.000247	0.000294	CcSEcCtD
Salbutamol—Musculoskeletal discomfort—Epirubicin—peripheral nervous system neoplasm	0.000245	0.000291	CcSEcCtD
Salbutamol—Shock—Doxorubicin—peripheral nervous system neoplasm	0.000245	0.000291	CcSEcCtD
Salbutamol—Nervous system disorder—Doxorubicin—peripheral nervous system neoplasm	0.000244	0.00029	CcSEcCtD
Salbutamol—Insomnia—Epirubicin—peripheral nervous system neoplasm	0.000243	0.000289	CcSEcCtD
Salbutamol—Tachycardia—Doxorubicin—peripheral nervous system neoplasm	0.000243	0.000289	CcSEcCtD
Salbutamol—Skin disorder—Doxorubicin—peripheral nervous system neoplasm	0.000242	0.000288	CcSEcCtD
Salbutamol—Paraesthesia—Epirubicin—peripheral nervous system neoplasm	0.000242	0.000287	CcSEcCtD
Salbutamol—Hyperhidrosis—Doxorubicin—peripheral nervous system neoplasm	0.000241	0.000286	CcSEcCtD
Salbutamol—Dyspnoea—Epirubicin—peripheral nervous system neoplasm	0.00024	0.000285	CcSEcCtD
Salbutamol—Somnolence—Epirubicin—peripheral nervous system neoplasm	0.000239	0.000284	CcSEcCtD
Salbutamol—Anorexia—Doxorubicin—peripheral nervous system neoplasm	0.000237	0.000282	CcSEcCtD
Salbutamol—Dyspepsia—Epirubicin—peripheral nervous system neoplasm	0.000237	0.000282	CcSEcCtD
Salbutamol—Decreased appetite—Epirubicin—peripheral nervous system neoplasm	0.000234	0.000278	CcSEcCtD
Salbutamol—Hypotension—Doxorubicin—peripheral nervous system neoplasm	0.000233	0.000277	CcSEcCtD
Salbutamol—Gastrointestinal disorder—Epirubicin—peripheral nervous system neoplasm	0.000232	0.000276	CcSEcCtD
Salbutamol—Fatigue—Epirubicin—peripheral nervous system neoplasm	0.000232	0.000276	CcSEcCtD
Salbutamol—Pain—Epirubicin—peripheral nervous system neoplasm	0.00023	0.000274	CcSEcCtD
Salbutamol—Constipation—Epirubicin—peripheral nervous system neoplasm	0.00023	0.000274	CcSEcCtD
Salbutamol—Musculoskeletal discomfort—Doxorubicin—peripheral nervous system neoplasm	0.000227	0.00027	CcSEcCtD
Salbutamol—Insomnia—Doxorubicin—peripheral nervous system neoplasm	0.000225	0.000268	CcSEcCtD
Salbutamol—Paraesthesia—Doxorubicin—peripheral nervous system neoplasm	0.000224	0.000266	CcSEcCtD
Salbutamol—Dyspnoea—Doxorubicin—peripheral nervous system neoplasm	0.000222	0.000264	CcSEcCtD
Salbutamol—Feeling abnormal—Epirubicin—peripheral nervous system neoplasm	0.000222	0.000264	CcSEcCtD
Salbutamol—Somnolence—Doxorubicin—peripheral nervous system neoplasm	0.000221	0.000263	CcSEcCtD
Salbutamol—Gastrointestinal pain—Epirubicin—peripheral nervous system neoplasm	0.00022	0.000262	CcSEcCtD
Salbutamol—Dyspepsia—Doxorubicin—peripheral nervous system neoplasm	0.000219	0.000261	CcSEcCtD
Salbutamol—Decreased appetite—Doxorubicin—peripheral nervous system neoplasm	0.000217	0.000257	CcSEcCtD
Salbutamol—Gastrointestinal disorder—Doxorubicin—peripheral nervous system neoplasm	0.000215	0.000256	CcSEcCtD
Salbutamol—Fatigue—Doxorubicin—peripheral nervous system neoplasm	0.000215	0.000255	CcSEcCtD
Salbutamol—Urticaria—Epirubicin—peripheral nervous system neoplasm	0.000214	0.000254	CcSEcCtD
Salbutamol—Pain—Doxorubicin—peripheral nervous system neoplasm	0.000213	0.000253	CcSEcCtD
Salbutamol—Constipation—Doxorubicin—peripheral nervous system neoplasm	0.000213	0.000253	CcSEcCtD
Salbutamol—Body temperature increased—Epirubicin—peripheral nervous system neoplasm	0.000213	0.000253	CcSEcCtD
Salbutamol—Abdominal pain—Epirubicin—peripheral nervous system neoplasm	0.000213	0.000253	CcSEcCtD
Salbutamol—Feeling abnormal—Doxorubicin—peripheral nervous system neoplasm	0.000205	0.000244	CcSEcCtD
Salbutamol—Gastrointestinal pain—Doxorubicin—peripheral nervous system neoplasm	0.000204	0.000242	CcSEcCtD
Salbutamol—Hypersensitivity—Epirubicin—peripheral nervous system neoplasm	0.000198	0.000236	CcSEcCtD
Salbutamol—Urticaria—Doxorubicin—peripheral nervous system neoplasm	0.000198	0.000235	CcSEcCtD
Salbutamol—Abdominal pain—Doxorubicin—peripheral nervous system neoplasm	0.000197	0.000234	CcSEcCtD
Salbutamol—Body temperature increased—Doxorubicin—peripheral nervous system neoplasm	0.000197	0.000234	CcSEcCtD
Salbutamol—Asthenia—Epirubicin—peripheral nervous system neoplasm	0.000193	0.00023	CcSEcCtD
Salbutamol—Pruritus—Epirubicin—peripheral nervous system neoplasm	0.00019	0.000226	CcSEcCtD
Salbutamol—Diarrhoea—Epirubicin—peripheral nervous system neoplasm	0.000184	0.000219	CcSEcCtD
Salbutamol—Hypersensitivity—Doxorubicin—peripheral nervous system neoplasm	0.000183	0.000218	CcSEcCtD
Salbutamol—Asthenia—Doxorubicin—peripheral nervous system neoplasm	0.000179	0.000212	CcSEcCtD
Salbutamol—Dizziness—Epirubicin—peripheral nervous system neoplasm	0.000178	0.000212	CcSEcCtD
Salbutamol—Pruritus—Doxorubicin—peripheral nervous system neoplasm	0.000176	0.000209	CcSEcCtD
Salbutamol—Vomiting—Epirubicin—peripheral nervous system neoplasm	0.000171	0.000203	CcSEcCtD
Salbutamol—Diarrhoea—Doxorubicin—peripheral nervous system neoplasm	0.00017	0.000203	CcSEcCtD
Salbutamol—Rash—Epirubicin—peripheral nervous system neoplasm	0.00017	0.000202	CcSEcCtD
Salbutamol—Dermatitis—Epirubicin—peripheral nervous system neoplasm	0.00017	0.000202	CcSEcCtD
Salbutamol—Headache—Epirubicin—peripheral nervous system neoplasm	0.000169	0.0002	CcSEcCtD
Salbutamol—Dizziness—Doxorubicin—peripheral nervous system neoplasm	0.000165	0.000196	CcSEcCtD
Salbutamol—Nausea—Epirubicin—peripheral nervous system neoplasm	0.00016	0.00019	CcSEcCtD
Salbutamol—Vomiting—Doxorubicin—peripheral nervous system neoplasm	0.000158	0.000188	CcSEcCtD
Salbutamol—Rash—Doxorubicin—peripheral nervous system neoplasm	0.000157	0.000187	CcSEcCtD
Salbutamol—Dermatitis—Doxorubicin—peripheral nervous system neoplasm	0.000157	0.000186	CcSEcCtD
Salbutamol—Headache—Doxorubicin—peripheral nervous system neoplasm	0.000156	0.000185	CcSEcCtD
Salbutamol—Nausea—Doxorubicin—peripheral nervous system neoplasm	0.000148	0.000176	CcSEcCtD
